A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. - Singh, Kirit; Foster, Matthew W.; Violette, Marlene J.; Corcoran, Anna M.; Hotchkiss, Kelly M.; Railton, Chelsea O.; Blandford, Emily E.; Blethen, Kathryn E.; Thomas, Elizabeth L.; McIntosh, William C.; Ashley, David M.; Desjardins, Annick; et al. (Scientific Reports, 2025)